• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.

作者信息

Lloyd-Jones Donald M, Wilkins John T

机构信息

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

J Am Coll Cardiol. 2023 Feb 21;81(7):633-635. doi: 10.1016/j.jacc.2022.12.007.

DOI:10.1016/j.jacc.2022.12.007
PMID:36792278
Abstract
摘要

相似文献

1
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.全生命周期心血管风险评估与预防：倾向、决定因素、风险、疾病
J Am Coll Cardiol. 2023 Feb 21;81(7):633-635. doi: 10.1016/j.jacc.2022.12.007.
2
Redefining Cardiovascular Risk Assessment as a Spectrum: From Binary to Continuous.将心血管风险评估重新定义为一个范围：从二元到连续。
J Am Coll Cardiol. 2024 Feb 6;83(5):574-576. doi: 10.1016/j.jacc.2023.11.026.
3
Focus on population studies in cardiovascular risk assessment.关注心血管风险评估中的人群研究。
Eur J Prev Cardiol. 2024 Jan 5;31(1):1-2. doi: 10.1093/eurjpc/zwad371.
4
Cardiovascular risk management requires a combination of cardiovascular preventive pharmacotherapy and non-pharmacological interventions.心血管风险管理需要结合心血管预防性药物治疗和非药物干预措施。
Eur J Prev Cardiol. 2022 Sep 7;29(12):e312-e313. doi: 10.1093/eurjpc/zwac082.
5
Editor comment: Focus on cardiovascular risk assessment.编辑评论：关注心血管风险评估。
Eur J Prev Cardiol. 2022 Mar 30;29(4):577-579. doi: 10.1093/eurjpc/zwac051.
6
Improving risk stratification in people with previous manifestations of cardiovascular disease: one size does not fit all in secondary prevention.改善有心血管疾病既往表现者的风险分层：二级预防中不存在适用于所有人的单一方案。
Eur J Prev Cardiol. 2024 Jan 25;31(2):216-217. doi: 10.1093/eurjpc/zwad334.
7
Editorial commentary: COVID-19 as a cardiovascular disease risk factor.编辑评论：新冠病毒病作为一种心血管疾病风险因素
Trends Cardiovasc Med. 2022 Nov;32(8):476-478. doi: 10.1016/j.tcm.2022.07.003. Epub 2022 Jul 16.
8
Dedicated devices for non-invasive cardiovascular risk assessment - the future of cardiovascular prevention.用于无创心血管风险评估的专用设备——心血管预防的未来。
Cardiol J. 2024;31(3):496-498. doi: 10.5603/cj.96477. Epub 2024 May 20.
9
Focus on cardiovascular risk factor control.关注心血管危险因素的控制。
Eur J Prev Cardiol. 2022 Oct 18;29(13):1715-1717. doi: 10.1093/eurjpc/zwac209.
10
Exploring the High Burden of Cardiovascular Disease Among Patients with End-Stage Renal Disease.探索终末期肾病患者中心血管疾病的高负担情况。
Curr Vasc Pharmacol. 2021;19(1):1-3. doi: 10.2174/157016111901201028093749.

引用本文的文献

1
Academic Lifestyle Medicine and Physician Education.学术生活方式医学与医生教育
Am J Lifestyle Med. 2025 Jun 27:15598276251355163. doi: 10.1177/15598276251355163.
2
Cardiologists' knowledge and implementation of lifestyle counselling for cardiovascular disease prevention: A national survey.心脏病专家关于预防心血管疾病的生活方式咨询的知识与实践：一项全国性调查。
Bioinformation. 2024 Dec 31;20(12):1948-1953. doi: 10.6026/9732063002001948. eCollection 2024.
3
Management recommendations to reduce cardiac risk in chronic epilepsy.
降低慢性癫痫患者心脏风险的管理建议。
Epilepsy Behav Rep. 2024 Dec 25;29:100738. doi: 10.1016/j.ebr.2024.100738. eCollection 2025 Mar.